Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-036430
Filing Date
2018-06-07
Accepted
2018-06-07 17:13:32
Documents
1
Period of Report
2018-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4033
  Complete submission text file 0001209191-18-036430.txt   5506
Mailing Address SYMANTEC CORPORATION 20330 STEVENS CREEK BLVD. CUPERTINO CA 95014
Business Address
MAHONEY DAVID L (Reporting) CIK: 0001224091 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 18887317

Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations